Isan Chen
2016
In 2016, Isan Chen earned a total compensation of $1.7M as Executive Vice President and Chief Medical and Development Officer at Mirati Therapeutics, a 62% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,136 |
|---|---|
| Option Awards | $1,179,389 |
| Salary | $411,032 |
| Other | $2,831 |
| Total | $1,688,388 |
Chen received $1.2M in option awards, accounting for 70% of the total pay in 2016.
Chen also received $95.1K in non-equity incentive plan, $411K in salary and $2.8K in other compensation.
Rankings
In 2016, Isan Chen's compensation ranked 5,674th out of 14,075 executives tracked by ExecPay. In other words, Chen earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,674 out of 14,075 | 60th |
Division Manufacturing | 2,054 out of 5,486 | 63rd |
Major group Chemicals And Allied Products | 657 out of 1,900 | 65th |
Industry group Drugs | 493 out of 1,543 | 68th |
Industry Pharmaceutical Preparations | 392 out of 1,173 | 67th |
Source: SEC filing on April 20, 2017.
Chen's colleagues
We found five more compensation records of executives who worked with Isan Chen at Mirati Therapeutics in 2016.
2016
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2016
Mark Gergen
Mirati Therapeutics
Former Executive Vice President and Chief Operations Officer
2016
James Christensen
Mirati Therapeutics
Chief Scientific Officer
2016
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
2016
Chris LeMasters
Mirati Therapeutics